CLINICAL_TRIALS
research
· 2025-08-29
Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Summary
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events during cell therapy for…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Hodgkin Lymphoma, Non Hodgkin Lymphoma | Status: COMPLETED